IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.430
+0.020 (1.42%)
Mar 3, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2022FY 2021FY 2019FY 2018FY 2017FY 2016FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Jan '16
Ophthalmology
48.67M51.87M56.97M53.90M36.35M
Ophthalmology Growth
-6.17%-8.96%5.69%48.30%-16.34%
Total
48.67M51.87M56.97M53.90M36.35M
Total Growth
-6.17%-8.96%5.69%48.30%-16.34%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2022FY 2021FY 2019FY 2018FY 2017FY 2016FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Dec '16 Jan '16
United States
22.69M26.05M29.18M24.95M19.31M
United States Growth
-12.91%-10.71%16.97%29.17%-13.28%
Europe, Middle East and Africa
11.82M13.52M13.80M13.97M-
Europe, Middle East and Africa Growth
-12.54%-2.04%-1.21%--
Asia/Pacific Rim
11.95M10.23M10.93M12.44M7.06M
Asia/Pacific Rim Growth
16.77%-6.38%-12.16%76.21%-16.19%
Americas Excluding the U.S.
2.21M2.06M3.06M2.54M1.97M
Americas Excluding the U.S. Growth
6.94%-32.64%20.37%29.28%-31.15%
Europe
----8.01M
Europe Growth
-----19.08%
Total
48.67M51.87M56.97M53.90M36.35M
Total Growth
-6.17%-8.96%5.69%48.30%-16.34%
Source: S&P Global Market Intelligence.